KAVAR CAPITAL PARTNERS GROUP, LLC - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
KAVAR CAPITAL PARTNERS GROUP, LLC ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q1 2022$2,798,000
+0.6%
64,238
+1.9%
0.60%
+4.7%
Q4 2021$2,780,000
+16.7%
63,038
+1.1%
0.58%
+6.4%
Q3 2021$2,383,000
+0.3%
62,353
+4.5%
0.54%
-5.4%
Q2 2021$2,377,000
+9.2%
59,688
-2.1%
0.57%
-2.2%
Q1 2021$2,177,000
-2.6%
60,988
+0.5%
0.59%
-8.7%
Q4 2020$2,234,00060,6930.64%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q3 2021
NameSharesValueWeighting ↓
Chubb Ltd 400,000$15,404,0006.76%
KAHN BROTHERS GROUP INC 833,315$32,090,960,0005.42%
Sio Capital Management, LLC 180,811$6,963,0004.06%
Sio Capital Management, LLC 170,000$6,547,0003.82%
OSTERWEIS CAPITAL MANAGEMENT INC 1,124,462$43,304,0003.12%
Keystone Financial Planning, Inc. 120,705$4,648,0003.04%
PVG Asset Management 186,553$7,184,156,0003.02%
P.R. Herzig & Co. Inc. 37,950$1,461,0002.98%
EQUITY INVESTMENT CORP 2,329,469$89,708,0002.89%
Sterneck Capital Management, LLC 114,816$4,422,0002.84%
View complete list of GLAXOSMITHKLINE PLC shareholders